Van Cleef Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
BG
Van Cleef Asset Management's BSX Position: Q3 2021 in Review
Van Cleef Asset Management sold out of Boston Scientific (BSX) in Q3 2021, closing a stake of 5,935 shares — an estimated $254K sold.
Van Cleef Asset Management first reported a position in BSX in Q2 2016 and held it in 21 quarters. The position peaked at $298K in Q4 2019. 877 funds tracked by Wall St. Rank hold BSX as of Q3 2021.
- Van Cleef Asset Management reported no remaining Boston Scientific position as of Q3 2021 after selling out during the quarter.
- Van Cleef Asset Management sold 5,935 Boston Scientific shares in Q3 2021, an estimated $254K.
- Van Cleef Asset Management first reported a position in Boston Scientific in Q2 2016 and held it in 21 quarters.
- Van Cleef Asset Management's Boston Scientific position peaked at $298K in Q4 2019.
- 877 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.
Based on Van Cleef Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.